Goldman Sachs
AH

Goldman Sachs’s Accretive Health AH Stock Holding History

Goldman Sachs’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-418,418
Closed -$3.35M – 7349
2014
Q1 		$3.35M Buy
418,418
+292,906
+233% +$2.59M ﹤0.01% 3482
2013
Q4 		$1.15M Buy
125,512
+72,210
+135% +$621K ﹤0.01% 4615
2013
Q3 		$486K Buy
53,302
+2,058
+4% +$20.5K ﹤0.01% 5174
2013
Q2 		$554K Buy
+51,244
New +$539K ﹤0.01% 4856

Other funds holding AH

JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
RMC
Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return
BCM
Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return
ECM
EII Capital Management New York $774K AUM 22.41% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
MIM
Merion Investment Management Bay Harbor Islands, Florida $1.26M AUM 28.57% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return
SCM
Stonebridge Capital Management Los Angeles, California $208M AUM

Goldman Sachs's AH Position: Q2 2014 in Review

Goldman Sachs sold out of Accretive Health (AH) in Q2 2014, closing a stake of 418,418 shares — an estimated $3.35M sold.

Goldman Sachs first reported a position in AH in Q2 2013 and held it in 4 quarters. The position peaked at $3.35M in Q1 2014. 12 funds tracked by Wall St. Rank hold AH as of Q2 2014.

  • Goldman Sachs reported no remaining Accretive Health position as of Q2 2014 after selling out during the quarter.
  • Goldman Sachs sold 418,418 Accretive Health shares in Q2 2014, an estimated $3.35M.
  • Goldman Sachs first reported a position in Accretive Health in Q2 2013 and held it in 4 quarters.
  • Goldman Sachs's Accretive Health position peaked at $3.35M in Q1 2014.
  • 12 funds tracked by Wall St. Rank held Accretive Health as of Q2 2014.

Based on Goldman Sachs's 13F filing for Q2 2014, filed 14 Aug 2014.